We leads the future of digital healthcare
with novel technology and robust business model.

Why Invest Noul

Noul is a decentralized diagnostic testing platform company established with the goal of improving medical access to essential diagnostic testing areas such as blood and cancer. With miLab™, an innovative diagnostic solution that enables accurate testing at the quality of large hospitals in conditions that lack laboratory infrastructure. We will draw a growth curve in the world’s high-demand diagnostic testing markets such as malaria, blood analysis, and cervical cancer. Noul will continue to increase the mid to long term investment value by leading the telemedicine and digital healthcare market, which are considered as the future of healthcare.


Noul believes in the establishment of a fair and transparent decision making and internal control system, which is a key requirement for securing the trust of stakeholders, and ensuring competitiveness in the market. We are establishing a sound governance structure through board-centered management, while making every effort to increase long-term corporate value by continuously enhancing the expertise, independence and diversity of board operations.

Inside Directors

ChanYang (David) Lim CEO, Chairman of the Board
  • (Current) Chief Executive Officer, Noul
  • (Former) Managing Partner, Sol Invest
  • (Former) Manager, Partners Investment
  • (Former) Business Dept. Head, MGB Endoscopy
  • B.S in Electrical & Computer Engineering, Seoul National University
KyungHwan (Peter) Kim Director
  • (Current) Chief Legal Officer, Noul
  • (Former) Lawyer, Korea Telecom
  • (Former) Senior Researcher, LG Electronics Inc. Institute for Future Internet Technology Convergence
  • M.S in Electrical & Computer Engineering, Seoul National University
  • B.S in Electrical & Computer Engineering, Seoul National University
JungKwon (Justin) Ahn Director
  • (Current) Chief Sustainability Officer, Noul
  • (Former) Chief Sustainability Officer, Slowalk
  • (Former) Senior Auditor, British Standards Institution
  • (Former) Senior Researcher, POSCO Research Institute
  • M.S in Environmental Management, Seoul National University
  • B.A in Business Management, Korea University

Outside Directors

Seon-Jee Lee
  • (Current) Outside Director, Noul
  • (Current) Attorney, Kim & Chang
  • (Current) Member, Public-Private Partnerships
    Deliberation Committee, Ministry of Economy and Finance
  • (Current) Member, Dispute Mediation Committee, Korea Exchange
  • Columbia University, School of Law (Visiting scholar)
  • Admitted to bar, Korea, 1999
  • College of Law, Seoul National University
Seongsoo Jang
  • (Current) Outside Director, Noul
  • (Current) Professor, University of Ulsan College of Medicine
  • (Current) Chairman of Board, The Korean Society of Hematology
  • MD, Hanyang University


From the foundation, Noul has pursued growth through embedding sustainability philosophy into our daily business system. Under the company’s sustainability strategy, we are enhancing investor and capital market’s expectations for environmental, social and governance.
Noul carries social venture designation bestowed by the Korea Ministry of SMEs and Startups, which is rare for healthcare startups, and preemptively acts to meet most of the requirements in the ESG evaluation of the exchange market.

Please summit investors' inquiries here.

For related inquiries, please contact email or call 070-4352-2014.

Contact Us